Skip to main content
NewslettersWatchlist

Metsera Inc(MTSR-Q)
NASDAQ

Today's Change
Delayed Last Update

Metsera Inc

3 WORLD TRADE CENTER 175 GREENWICH STREET
NEW YORK NY 10007 USA
P: 212-784-6595
http://www.metsera.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Metsera Inc. is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight and related conditions. Metsera Inc. is based in NEW YORK.

    Key Executives

    NameTitle
    Matthew LangChief Legal Officer/Secretary

    More from The Globe

    AI trade splinters across stocks, sectors and regions as investors get more selective
    FILE PHOTO: Figurines with computers and smartphones are seen in front of the words "Artificial Intelligence AI" in this illustration taken, February 19, 2024. REUTERS/Dado Ruvic/Illustration/File Photo
    the mover
    Why this money manager is buying Adobe and selling Oracle
    Illustration of John Zechner Illustration by Joel Kimmel
    top links
    Barlow’s Research Roundup: Strong global interest in Canadian income-oriented energy infrastructure stocks
    Workers place pipe during construction of the Trans Mountain pipeline expansion on farmland, in Abbotsford, B.C., on Wednesday, May 3, 2023.
    Thomson Reuters reports higher quarterly revenue driven by legal, tax and accounting businesses
    Employees of Thomson Reuters, which transferred its listing to Nasdaq in February, react as the company's logo is displayed on a screen at Nasdaq MarketSite in New York City, U.S., November 19, 2025. REUTERS/Brendan McDermid
    Analysts’ forecast returns, recommendations and yields for all stocks in the S&P 500
    A screen displays the Dow Jones Industrial Average after the closing bell at the New York Stock Exchange (NYSE) in New York City, U.S., January 21, 2026.
    Anthropic’s release of AI tools for lawyers prompts massive legal-tech sell-off
    Anthropic launched plug-ins for its Claude Cowork AI agent on Friday, enabling automation across legal, sales, marketing and data analytics. Photo illustration by Jonathan Raa/NurPhoto
    number cruncher
    10 Canadian stocks with flexibility to thrive in uncertain markets
    For Number Cruncher column in Globe Investor/ROB only.
    Bullish on Chevron Corp.
    Monica Rizk

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.